Fergie J, Howard A, Huang L, et al. - Since 2015, recommendation has been made by the Advisory Committee on Immunization Practices (ACIP) for vaccination of healthy adolescents against meningococcal serogroup B (MenB) based on shared clinical decision-making (previously called “Category B” or individual clinical decision-making). Researchers sought to report the implementation experience of adolescent MenB vaccination in the United States under this nonroutine ACIP recommendation. Searching PubMed they identified studies yielding evidence that ACIP’s MenB vaccination recommendation is poorly understood and prone to misinterpretation by US healthcare providers. They indicated low parental awareness concerning MenB vaccines, and racial and socioeconomic disparities regarding vaccine receipt. Based on five years of evidence concerning the MenB vaccination implementation experience, they suggest that low vaccine coverage is partly because of the nonstandard recommendation for MenB vaccines. In addition, limitation in access to MenB vaccines could have occurred due to inconsistent implementation of ACIP recommendations. They emphasize the necessity for additional support and guidance among providers for implementing the shared clinical decision-making recommendation, in turn ensuring equitable access for vaccine-eligible adolescents to enable comprehensive protection against meningococcal disease.